The PA6 stromal cell line comprises a heterogeneous population of cells that can induce both mouse and human embryonic stem cells to differentiate into dopaminergic neurons. This ability of PA6 cells has been termed stromal cell-derived inducing activity (SDIA). The level of SDIA has been found to vary considerably between and within batches of PA6 cells. Not only are the molecular mechanisms that underlie SDIA unknown but also the cell type(s) within the heterogeneous PA6 cultures that underlie SDIA remain poorly defined. In this study, we reveal that adipocytes, which are present within the heterogeneous PA6 cell population, robustly release the factors mediating SDIA. Furthermore, we report that the coculture of human embryonic stem cell...
Dopamine (DA) neurons derived from human embryonic stem cells (hESCs) are potentially valuable in dr...
The striatal dopamine (DA) deficiency is known as the main cause of the clinical picture of Parkinso...
Our ability to use human embryonic stem (hES) cells in cell replacement therapy for Parkinson’s dise...
Previous evidence has shown that stromal cell-derived inducing activity (SDIA), produced by the mous...
Human embryonic stem cells (hESCs) are a promising source for cell replacement therapies. Parkinson'...
Parkinson’s disease is a progressive neurodegenerative disorder. Since the motor manifestations of t...
Since the first successful derivation of human embryonic stem cells (hESC), rapid progress has been ...
BACKGROUND:Stromal-Derived Inducing Activity (SDIA) is one of the most efficient methods of generati...
Stromal-Derived Inducing Activity (SDIA) is one of the most efficient methods of generating dopamine...
Several studies have demonstrated the differentiation of human adipose tissue-derived stem cells (hA...
Background Understanding how lineage choices are made during embryonic stem (ES) cell differentiati...
AbstractWe have identified a stromal cell–derived inducing activity (SDIA) that promotes neural diff...
he capacity of pluripotency and self-renewal of human embryonic stem (hES) cells may provide unlimit...
Directing the fate of mesenchymal stem cells (MSCs) to dopaminergic neurons has great importance in ...
Dopamine (DA) neurons derived from human embryonic stem cells (hESCs) are potentially valuable in dr...
Dopamine (DA) neurons derived from human embryonic stem cells (hESCs) are potentially valuable in dr...
The striatal dopamine (DA) deficiency is known as the main cause of the clinical picture of Parkinso...
Our ability to use human embryonic stem (hES) cells in cell replacement therapy for Parkinson’s dise...
Previous evidence has shown that stromal cell-derived inducing activity (SDIA), produced by the mous...
Human embryonic stem cells (hESCs) are a promising source for cell replacement therapies. Parkinson'...
Parkinson’s disease is a progressive neurodegenerative disorder. Since the motor manifestations of t...
Since the first successful derivation of human embryonic stem cells (hESC), rapid progress has been ...
BACKGROUND:Stromal-Derived Inducing Activity (SDIA) is one of the most efficient methods of generati...
Stromal-Derived Inducing Activity (SDIA) is one of the most efficient methods of generating dopamine...
Several studies have demonstrated the differentiation of human adipose tissue-derived stem cells (hA...
Background Understanding how lineage choices are made during embryonic stem (ES) cell differentiati...
AbstractWe have identified a stromal cell–derived inducing activity (SDIA) that promotes neural diff...
he capacity of pluripotency and self-renewal of human embryonic stem (hES) cells may provide unlimit...
Directing the fate of mesenchymal stem cells (MSCs) to dopaminergic neurons has great importance in ...
Dopamine (DA) neurons derived from human embryonic stem cells (hESCs) are potentially valuable in dr...
Dopamine (DA) neurons derived from human embryonic stem cells (hESCs) are potentially valuable in dr...
The striatal dopamine (DA) deficiency is known as the main cause of the clinical picture of Parkinso...
Our ability to use human embryonic stem (hES) cells in cell replacement therapy for Parkinson’s dise...